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ABSTRACT. The simplicity of cobalt units gives them the advantage of reduced
maintenance, running costs and downtime when compared with linear accelerators.
However, treatments carried out on such units are typically limited to simple
techniques. This study has explored the use of cobalt beams for conformal and
intensity-modulated radiotherapy (IMRT). Six patients, covering a range of treatment
sites, were planned using both X-ray photons (6/10 MV) and cobalt-60 gamma rays
(1.17 and 1.33 MeV). A range of conformal and IMRT techniques were considered, as
appropriate. Conformal plans created using cobalt beams for small breast, meningioma
and parotid cases were found to compare well with those created using X-ray photons.
By using additional fields, acceptable conformal plans were also created for
oesophagus and prostate cases. IMRT plans were found to be of comparable quality for
meningioma, parotid and thyroid cases on the basis of dose–volume histogram analysis.
We conclude that it is possible to plan high-quality radical radiotherapy treatments for
cobalt units. A well-designed beam blocking/compensation system would be required
to enable a practical and efficient alternative to multileaf collimator (MLC)-based linac
treatments to be offered. If cobalt units were to have such features incorporated into
them, they could offer considerable benefits to the radiotherapy community.
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With the advance of increasingly complex treatment
techniques in radiotherapy, there is a tendency to move
towards ever more sophisticated and expensive external
beam delivery equipment. The use of conformal radio-
therapy (CFRT) is now routine in most centres, with
intensity-modulated radiotherapy (IMRT) also becoming
more widespread. Both CFRT and IMRT are usually
implemented using a linear accelerator fitted with a
multileaf collimator (MLC), to create the conformality
and fluence variations necessary [1]. However, the
complexity of such machines leads to high maintenance
costs and significant planned and unplanned downtime
[2, 3].
The advantages of cobalt units, with their very low
maintenance costs and minimal need for engineering
support, are well known to the radiotherapy community.
The net gains in reviving a safer generation of such
simple, economical machines could be considerable in a
world with increasingly stretched health-care resources.
The current generation of three-dimensional treatment
planning systems, networked to commercial block and
compensator cutters, could provide a practical means of
delivering high-quality, radical radiotherapy treatments
on cobalt units.
A planning study has therefore been carried out to
compare cobalt-60 (Co-60) plans, using conformal blocks
and/or compensators, with those created using a 6/10 MV
linear accelerator and MLC.
Methods and materials
Planning comparisons were carried out for seven
clinical sites using both photons (6/10 MV) and Co-60.
Cobalt plans used data from a Theratron Elite cobalt unit
(MDS Nordion, Kanata, Canada) and photon plans used
data from an Elekta SL15 dual energy accelerator (Elekta,
Crawley, UK). The clinical sites were chosen to cover a
range of plan complexity, from conventional planning to
IMRT, using divergent blocks and compensators for the
cobalt unit and a MLC for the accelerator. Planning was
carried out on a Helax-TMS system (v6.0.2) (Nucletron
UK, Cheshire, UK) using CT scans from previously
treated patients. Dose distributions were calculated
using a pencil beam calculation algorithm [4].
Conformal plans were normalized such that the planning
target volume (PTV) doses were within 95–107% of the
prescription dose, ideally with a median dose of 100%
[5]. IMRT optimizations also aimed to fulfil these goals
although a minimum dose of 90% was considered
acceptable provided that 95% of the PTV was enclosed
within the 95% isodose; if necessary, IMRT plans were
normalized after optimization to achieve this. For the
PTVs, minimum and maximum doses (defined as the
dose received by 99% and 1% of the volume respectively)
were recorded, as were the median dose and the volume
covered by the 95% isodose (V95%). For organs at risk
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(OARs), dose–volume parameters appropriate for the
particular organ, based on the tolerance values, were
recorded.
Breast
A patient with right-sided breast cancer was consid-
ered for this comparison. The patient separation at the
base of the breast was 17 cm, representing a small breast
[6], and the maximum lung depth encompassed by the
standard tangential fields (measured in beam’s eye view)
was 1.1 cm. The whole of the breast, excluding the 5 mm
beneath the surface of the skin, was contoured as the
PTV. Plans were created for Co-60 and 6 MV photons
using opposing rectangular wedged tangential fields,
angled to give a non-divergent posterior edge. The
prescribed dose was 50 Gy.
Oesophagus
The clinical target volume (CTV) for this site com-
prised the oesophageal tumour with a margin for
microscopic spread and the adjacent lymph nodes. This
was extended by 3 cm in the superior/inferior direction
by contouring, tracking along the oesophagus, and then a
15 mm margin was added circumferentially to create the
PTV. Planning was carried out using four conformal
fields (gantry angles 0 ,˚ 90 ,˚ 180 ,˚ 270 )˚, shaped using a
MLC and blocks for 6 MV and Co-60, respectively. The
prescribed dose to the PTV was 54 Gy. The OARs were
the spinal cord, to which a maximum dose of 46 Gy was
allowed, and the lungs, 20% of which were required to
remain below 20 Gy [7].
Meningioma
The CTV in this case was an irregularly shaped base-
of-skull meningioma to which a 5 mm margin was
added in three dimensions to create the PTV. The
prescribed dose was 55 Gy. The brain and brainstem
were considered as OARs; although the dose employed
was within tolerance limits for these structures [8],
functional damage to the brain is both dose and volume
dependent and hence it is desirable to limit the volume
of normal brain irradiated. Dose to the eyes was
minimized by avoiding beam directions that passed
through them. CFRT plans were created for Co-60 and
6 MV photons using four and six non-coplanar fields
with conformal blocks. Use of conformal blocks for this
treatment site is normal clinical practice at our centre
because of their superior shaping ability compared with
the 1 cm MLC leaves. Additionally, IMRT plans were
created for both modalities using the six-field arrange-
ment, using conformal blocks and compensators. In
practice, intensity modulation on the accelerator could be
achieved using the MLC; however, the planning system
would not allow the use of both a MLC and blocks on the
same beam.
Parotid
The CTV for this case consisted of the radiographically
visible parotid gland surgical bed and the ipsilateral
upper cervical lymph nodes, to which a 5 mm margin
was applied in three dimensions, excluding the 5 mm
beneath the skin surface, to create the PTV. The main
OARs under consideration were the ipsilateral cochlea,
which lay very close to the PTV, and the contralateral
parotid gland. Dose to the eyes was minimized by
avoiding beam directions that passed through them, and
doses to the oral cavity, brain and brainstem were also
considered. Conformal wedged pair and four-field IMRT
plans (gantry angles 15 ,˚ 40 ,˚ 140˚ and 170˚ [9]) were
created using 6 MV photons with a MLC, and Co-60 with
blocks or compensators. The prescribed dose was 60 Gy.
Prostate
The CTV in this case consisted of the prostate plus
seminal vesicles, to which a 10 mm margin was added in
three dimensions to create the PTV. The prescribed dose
was 70 Gy. The main OAR of concern was the rectum,
although bladder and femoral heads were also consid-
ered; planning goals for the OARs can be seen in Table 1
[10]. A standard three-field conformal plan (gantry
angles 0 ,˚ 90 ,˚ 270 )˚ was prepared using 10 MV photons
and a MLC, and then compared with a five-field Co-60
plan (gantry angles 30 ,˚ 90 ,˚ 180 ,˚ 270 ,˚ 330 )˚ prepared
using conformal blocks. More fields were necessary for
the Co-60 plan to keep the doses near the surface of the
patient to an acceptable level. Additionally, a six-field
non-coplanar Co-60 plan was created, using an anterior
and posterior field and lateral fields with the couch
twisted by ¡30˚ (the maximum couch twist possible
avoiding collision with the treatment head).
Table 1. Planning goals and dose statistics for prostate plans
Organ at risk Dose (Gy) Maximum volume (%) Volume achieved (%)
10 MV 5f Co-60 6f Co-60
Bladder 50 50 17.3 14.0 14.9
60 25 13.7 9.4 10.0
70 5 3.6 3.4 3.2
Rectum 50 60 36.0 35.3 37.6
60 50 30.6 29.6 30.6
65 30 27.3 26.5 25.5
70 15 12.5 11.6 7.2
Femoral heads 50 50 0.0 0.0 0.0
5f, five-field; 6f, six-field.
Cobalt vs linac CFRT and IMRT
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Thyroid
For this case the CTV consisted of the thyroid bed and
immediately adjacent lymphatics, to which a 5 mm
margin was added in three dimensions, excluding the
5 mm beneath the skin surface, to create the PTV. In this
situation, where the PTV wraps around the spinal cord,
conventional and conformal techniques are unable to
deliver the prescribed dose of 60 Gy to the target without
exceeding the spinal cord tolerance of 46 Gy [11]; hence,
only IMRT plans were considered. Five coplanar fields
were used for both Co-60 with compensators and 6 MV
photons with a MLC.
Results
Breast
The minimum and maximum PTV doses for the 6 MV
plan were 97.2% and 105.3% (median 100.0%) of the
prescribed dose respectively; those for the Co-60 plan
were 94.5% and 105.7% (median 101.1%) respectively. As
the PTV coverage was slightly lower for the Co-60 plan, a
second plan was created in which a low-weighted
segment was added to the anterior oblique beam with
a wedge in the cranio-caudal direction. This second plan
had a minimum PTV dose of 95.8% and a maximum of
106.3% (median 101.0%). The volume of lung receiving
doses below 25 Gy was slightly increased in the Co-60
plans; however, the lung doses were still perfectly
acceptable (volume receiving .20 Gy (V20 Gy) was
2.2% for 6 MV, 3.4% for both Co-60 plans).
Oesophagus
Table 2 lists the dose statistics for the oesophagus
plans. Spinal cord and lung doses were both within
tolerance; however, the cobalt plan showed poorer target
coverage and homogeneity than the 6 MV plan. This was
partly due to the large variation in effective path length
across the anterior field, where the central part of the
beam passes through soft tissue and bone, and the edges
pass through a large proportion of lung. This gives rise to
large hotspots at the lateral sides of the PTV (see
Figure 1a). A second cobalt plan was created, which
delivered part of the anterior beam dose through a
rectangular segment that included the mediastinum but
not the lungs (see Figure 1b). This led to improved target
homogeneity as indicated in Table 2.
Meningioma
Table 3 shows the PTV dose statistics for the menin-
gioma plans. In all cases the median dose was 100.0%.
The PTV was fully encompassed by the 95% isodose for
all conformal plans (V95%5100.0%); for the IMRT plans,
V95% was 98.6% for 6 MV and 97.8% for Co-60. Figure 2
shows the dose–volume histograms (DVHs) for the brain
and brainstem.
Parotid
Table 4 shows the dose statistics for the parotid case.
The minimum PTV dose for the 6 MV IMRT plan was
below the goal of 95%; V95% for this plan was 96.4%. The
OAR doses were similar between the two modalities.
The IMRT plans showed reductions in the doses to the
cochlea, oral cavity and contralateral parotid whereas the
brainstem doses were increased; however, the brainstem
doses were still well within the tolerance of 55 Gy for
this structure.
Prostate
Figure 3 shows the DVHs for the PTV, rectum and
bladder. The minimum and maximum PTV doses for the
10 MV plan were 97.0% and 105.4% (median 100.0%) of
the prescribed dose, respectively; those for the five-field
Co-60 plan were 95.0% and 105.3% (median 100.7%),
respectively, whereas those for the six-field Co-60 plan
were 95.2% and 105.0% (median 100.0%) respectively.
Table 1 gives the dose statistics for the OARs compared
with the plan acceptance criteria.
Thyroid
Figure 4 shows a transverse slice through the dose
distribution for the 6 MV and Co-60 plans. In both
cases the isodoses conform tightly around the con-
cavity in the PTV, sparing the spinal cord. Minimum
and maximum PTV doses for the 6 MV plan were 92.7%
and 105.7% (median 100.7%), respectively, whereas for
the Co-60 plan they were 90.0% and 105.7% (median
100.0%), respectively. V95% was 95.0% for the 6 MV
plan and 96.2% for the Co-60 plan. The maximum dose
to the spinal cord was 38.5 Gy for the 6 MV plan
and 46.2 Gy for the Co-60 plan; the doses received
by 1 ml of the spinal cord were 36.8 Gy and 38.6 Gy,
respectively.
Table 2. Dose statistics for oesophagus plans
6 MV Co-60 Co-60 + segment
PTV Minimum dose (%) 95.2 92.3 93.3
Maximum dose (%) 106.7 108.7 106.5
Median dose (%) 99.6 99.6 100.0
V95% (%) 99.3 94.0 96.4
Spinal cord Maximum dose (Gy) 40.3 41.9 42.0
Lungs Volume .20 Gy (%) 13.6 16.2 17.0
PTV, planning target volume.
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Discussion
As complex radiotherapy techniques become more
widespread, there is a tendency for departments to move
away from using cobalt units in favour of more
sophisticated delivery techniques. However, the simpli-
city of cobalt units leads to lower maintenance costs and
staffing needs as well as exceptional reliability. This
paper therefore aimed to investigate the potential of such
machines for conformal radiotherapy and IMRT. The
treatment sites and plan types were chosen to cover a
range of complexity, from simple rectangular fields
through to conformal techniques and complex inverse-
planned IMRT, including both superficial and deep-
seated lesions. Only a single patient case was considered
for each site, and hence the results cannot be considered
as conclusive; however, they do demonstrate the
possibility of designing complex radiotherapy treat-
ments using cobalt.
Plans created for a small-breasted patient showed that
cobalt offers a suitable alternative to 6 MV at this site.
Although the original cobalt plan did not entirely
encompass the PTV with the 95% isodose (minimum
dose 94.5%), this was easily rectified by the addition of a
wedge in the cranio-caudal direction. This latter cobalt
plan showed slightly increased inhomogeneity com-
pared with the 6 MV plan but was within standard
International Commission on Radiation Units (ICRU)
acceptance criteria. Lung doses were also slightly
increased for the cobalt plan because of the larger
penumbra for this modality but were still within
tolerance criteria.
Two sites were considered to investigate the role of
cobalt for conformal planning in the head: meningioma
and parotid. In both cases, plans for the two modalities
were very similar. The cobalt plans tended to show
increased PTV inhomogeneity; for the meningioma case
this was still well within acceptable limits and for the
parotid the maximum dose only just exceeded the goal of
107% (107.2%) and was therefore considered acceptable.
Increasing the number of fields in the meningioma case
led to improved OAR sparing at higher dose levels;
although the cobalt plans showed slightly increased
brain irradiation at some dose levels, these differences
were small compared with those caused by changing the
number of fields. For the parotid, all OAR doses were
comparable. These two treatment sites indicate that
cobalt is a suitable modality for planning tumours in
the head.
Conformal plans were also created for oesophagus and
prostate tumours. For the oesophagus case, the initial
cobalt plan showed poor PTV coverage and homogene-
ity. However, the addition of a rectangular segment to
the anterior beam was able to significantly improve the
dose distribution. Although the minimum PTV dose was
still below the 95% level suggested by the ICRU [5], it
was above 93% and more than 95% of the PTV volume
was enclosed by the 95% isodose (V95%596.4%); this
(a) (b)
Figure 1. Coronal distribution for Co-60 oesophagus plan (a) without and (b) with an anterior beam segment (shown dashed).
Isodoses shown are 10 Gy, 20 Gy, 30 Gy (dark grey), 40 Gy, 49 Gy (light grey), 51 Gy and 57 Gy (mid-grey).
Table 3. Planning target volume (PTV) dose statistics for meningioma plans
6 MV 4f CFRT Co-60 4f CFRT 6 MV 6f CFRT Co-60 6f CFRT 6 MV 6f IMRT Co-60 6f IMRT
Minimum dose (%) 98.2 97.2 96.6 96.0 94.0 93.3
Maximum dose (%) 102.2 102.9 102.5 102.4 105.4 104.9
4f, four-field; 6f, six-field; CFRT, conformal radiotherapy; IMRT, intensity-modulated radiotherapy.
Cobalt vs linac CFRT and IMRT
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would be considered acceptable at our institution. OAR
doses were slightly higher for the cobalt plans than for
6 MV, but all were within acceptable limits. This
indicates that Co-60 is a suitable modality for planning
tumours in the thoracic region. The PTV coverage for the
6 MV plan was better than that for the cobalt plans;
however, for this tumour site, the limitations of the
pencil beam model used in this study will affect the
calculated dose distribution, as neither the lack of scatter
from adjacent lung tissue nor the build-up effect for
beams passing through lungs will be properly accounted
for. In reality, therefore, hotspots will be reduced, as will
the coverage of the target in regions where the tumour is
next to lung tissue. This latter effect will be more
pronounced for 6 MV photons than for Co-60 as the
build-up depth is greater, hence making the two
modalities more comparable or possibly giving an
advantage to the Co-60 plan [12]. A full investigation of
this is outside the scope of this study but will be the
subject of future work.
Plans using Co-60 were also able to satisfy tolerance
criteria for the prostate case; although the PTV coverage
was worse for the Co-60 plans than for the 10 MV plan,
the minimum dose was above 95% in all cases. The
maximum PTV dose was comparable for all plans and all
OARs were within the plan acceptance criteria. The
bladder doses were lower in the Co-60 plans because of
the beam arrangement. Although the five-field Co-60
plan showed higher rectal doses in the 25–50 Gy region,
the plans were all very similar for doses above 50 Gy; if
doses in the 25–50 Gy region were considered to be
important, the six-field Co-60 plan could be used, which
gave similar results to those obtained with 10 MV. The
need for an increase in the number of fields compared
with the 10 MV plan, to maintain normal tissue doses,
leads to the cobalt plans being less efficient than the
corresponding linac plan. This is particularly true for the
non-coplanar six-field plan, although the plan was
designed with only two couch positions, thus minimiz-
ing the extra effort required. However, this case
illustrates that it is possible to treat deep-seated
malignancies in the pelvis using Co-60, which have long
been cited as being generally unsuitable for this treat-
ment modality.
IMRT planning with cobalt was investigated for parotid,
meningioma and thyroid treatment sites. For the parotid
case, use of Co-60 IMRT improved both PTV homogeneity
and OAR sparing compared with the conformal plan, with
the exception of the brainstem, which was still well within
tolerance. As for the conformal plans, the differences
between the two modalities were small. For the 6 MV
IMRT plans, the PTV coverage was reduced compared
with the conformal case, with a minimum dose of only
93.1%; however, 96.4% of the PTV was enclosed within the
(a) (b)
Figure 2. Dose–volume histograms for (a) brainstem and (b) brain from meningioma plans: four-field conformal radiotherapy
(CFRT) (solid), six-field CFRT (dotted) and six-field intensity-modulated radiotherapy (IMRT) (crosses) for Co-60 (grey) and 6 MV
(black) plans.
Table 4. Dose statistics for parotid plans
6 MV 2f CFRT Co-60 2f CFRT 6 MV 4f IMRT Co-60 4f IMRT
PTV Minimum dose (%) 95.0 95.0 93.1 95.2
Maximum dose (%) 105.9 107.2 105.8 105.2
Median dose (%) 100.9 100.0 100.1 100.0
Cochlea Mean dose (Gy) 38.8 38.8 29.8 30.8
Oral cavity Mean dose (Gy) 26.3 25.3 19.6 19.0
Contralateral parotid Mean dose (Gy) 1.7 2.7 1.4 2.2
Brainstem Maximum dose (Gy) 30.9 28.9 36.8 39.3
2f, two-field; 4f, four-field; CFRT, conformal radiotherapy; IMRT, intensity-modulated radiotherapy, PVT, planning target
volume.
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95% isodose, which is above the criterion of 95% often used
for IMRT planning. The meningioma IMRT plans were also
comparable between the two modalities, with a significant
improvement in OAR doses compared with the conformal
plans. Both modalities showed a reduction in PTV coverage
compared with the conformal cases, with minimum PTV
doses below 95%; however, in both cases V95% was greater
than 95% (98.6% for 6 MV, 97.8% for Co-60). The cobalt
plan showed a small increase in the volume of brainstem
treated to .40 Gy compared with the 6 MV plan, with a
significant decrease at lower doses; for the brain, cobalt
generally showed a small increase at all dose levels. As for
the conformal plans, these differences between modalities
were smaller than those between plan types.
For the thyroid case, both modalities were able to
cover the PTV with the 90% isodose, with at least 95% of
the volume covered by the 95% isodose, whilst sparing
the spinal cord. Although the maximum cord dose for
the cobalt plan (46.2 Gy) was slightly above the planned
constraint of 46 Gy, this dose was only recorded for a
very small volume of the cord; the dose received by a
more clinically relevant volume (1 mL) was 38.6 Gy.
The Co-60 plans generated in this study used
divergent, shaped blocks and/or compensators.
Although these beam-shaping devices provide a ‘‘gold
standard’’ of conformality, their use in X-ray radio-
therapy has been discontinued in many departments
because of concerns of overall efficiency, with the MLC
providing a more practical alternative. Although it is
possible for MLCs to be fitted to cobalt heads, this
increase in complexity may compromise the much-
cherished simplicity of these machines. Practical CFRT/
IMRT delivery on cobalt units would therefore require a
well-designed beam blocking/compensation system in
order to be an efficient alternative to MLC-based linac
treatments. Such a system has been designed by Yoda
and Aoki [13], who quote a delivery time of approxi-
mately 2 min for a six-field compensated treatment on an
accelerator, with approximately 1 min for gantry and
collimator rotations, assuming a 2 Gy min21 beam
intensity and 2 Gy isocentre dose. Measurements made
on a cobalt unit within our department [14], with a
2 Gy min21 source intensity, have suggested IMRT beam
delivery times of 20–75 s for a 2 Gy isocentre dose,
which, although longer than the times quoted by Yoda
and Aoki [13], compare well to linac-based IMRT
treatments. A further requirement for precise, radical
treatments is the ability to perform verification imaging,
preferably electronically; this should be potentially
realizable at this energy.
Figure 3. Dose–volume histograms from prostate plans.
Planning target volume (PTV) (solid), rectum (dotted) and
bladder (crosses) are shown for 10 MV (black), five-field
coplanar Co-60 (mid-grey) and six-field non-coplanar Co-60
(light grey) plans.
(a) (b)
Figure 4. Transverse dose distributions for (a) 6 MV and (b) Co-60 intensity-modulated radiotherapy (IMRT) thyroid plans.
Isodoses shown are 10 Gy, 20 Gy, 30 Gy, 40 Gy (dark grey), 50 Gy, 54 Gy (light grey), 57 Gy and 63 Gy (mid-grey).
Cobalt vs linac CFRT and IMRT
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Conclusions
Plans of varying complexity, including conformal
and IMRT techniques, have been created for Co-60
using blocks and/or compensators for a range of
treatment sites. In all cases, the cobalt plans were
comparable to those created using 6/10 MV photons
with an MLC; in most cases, this was achieved with
the same beam arrangement although in some cases,
such as the prostate, additional fields were required.
These results suggest that it is possible to design high-
quality radical radiotherapy treatments using cobalt
units. To be able to offer an efficient alternative to
MLC-based linac treatments, CFRT/IMRT delivery on
cobalt units would require a well-designed beam
blocking/compensation system and the ability to per-
form electronic verification imaging. If cobalt units
were to have such features incorporated into them, they
could offer considerable benefits to the radiotherapy
community.
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